Management of refractory autoimmune hemolytic anemia via allogeneic stem cell transplantation.

about

Management of refractory autoimmune hemolytic anemia via allogeneic stem cell transplantation.

Item

http://www.wikidata.org/entity/Q52839308

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Management of refractory autoi ...... eic stem cell transplantation.

@en

Management of refractory autoi ...... eic stem cell transplantation.

@nl

type

Item

label

Management of refractory autoi ...... eic stem cell transplantation.

@en

Management of refractory autoi ...... eic stem cell transplantation.

@nl

prefLabel

Management of refractory autoi ...... eic stem cell transplantation.

@en

Management of refractory autoi ...... eic stem cell transplantation.

@nl

P1476

Management of refractory autoi ...... eic stem cell transplantation.

@en

P2093

A Nathan

http://www.w3.org/2001/XMLSchema#string

A Parnes

http://www.w3.org/2001/XMLSchema#string

I Ghobrial

http://www.w3.org/2001/XMLSchema#string

J Antin

http://www.w3.org/2001/XMLSchema#string

L Rotenstein

http://www.w3.org/2001/XMLSchema#string

P2860

Cold agglutinin disease

Ibrutinib in previously treated Waldenström's macroglobulinemia.

Autoimmune hemolytic anemia

Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease

Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180.

Complement deposition in autoimmune hemolytic anemia is a footprint for difficult-to-detect IgM autoantibodies

Autoimmune manifestations in patients with Waldenström macroglobulinemia.

How I treat Waldenström macroglobulinemia.

TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins.

P2888

bmt.2016.152

P304

1504-1506

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2016.152

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27272445

http://www.w3.org/2001/XMLSchema#string